Coagulopathy in Hemorrhagic Fever with Renal Syndrome

The pathophysiology of bleeding manifestations in hemorrhagic fever with renal syndrome (HFRS) was elucidated by serially evaluating coagulation and fibrinolytic profiles and complement alterations in patients with HFRS. In the early stage of the disease, platelet counts, platelet survival time, and platelet aggregation in vitro decreased. Prolongation of bleeding time, prothrombin time, and activated partial thromboplastin time was noted, with decreases in coagulation factors II, V, VIII, IX, and X. Levels of fibrinogen were decreased, and those of fibrinogen-fibrin degradation products in serum and urine were increased. Concentrations of plasminogen, a2-plasmin inhibitor, and antithrombin III in plasma were depressed. Procoagulant activity was present in plasma. Circulating immune complexes were found, whereas serum levels of C3 were decreased. In the early stage of HFRS, thrombocytopenia, defects in platelet function, and disseminated intravascular coagulation may play central roles in the pathogenesis of bleeding manifestations. Vasculopathy and immunologic aberrations also may play a role.

[1]  M. Lee,et al.  Procoagulant activity and thrombelastography in Korean hemorrhagic fever. , 1986, Journal of Korean medical science.

[2]  J. Park,et al.  Circulating Immune Complexes in Korean Hemorrhagic Fever -Hemorrhagic Fever with Renal Syndrome- , 1986 .

[3]  B. Kim,et al.  Electron Microscopic Features of Bone Marrow Cells in Korean Hemorrhagic Fever , 1986 .

[4]  B. Kim,et al.  A Study on Thrombokinetics In Korean Hemorrhagic Fever , 1985 .

[5]  Gu Xs Activation of the alternative complement pathway in patients with epidemic hemorrhagic fever , 1983 .

[6]  J. McCormick,et al.  Detection of Viral Antigens in Formalin‐fixed Specimens by Enzyme Treatment , 1983, Annals of the New York Academy of Sciences.

[7]  B. Kim,et al.  Disseminated intravascular coagulation in Korean hemorrhagic fever. , 1983, Bibliotheca haematologica.

[8]  J. Huggins,et al.  HANTAAN VIRUS, AETIOLOGICAL AGENT OF KOREAN HAEMORRHAGIC FEVER, HAS BUNYAVIRIDAE-LIKE MORPHOLOGY , 1982, The Lancet.

[9]  J. McCormick,et al.  MORPHOLOGICAL IDENTIFICATION OF THE AGENT OF KOREAN HAEMORRHAGIC FEVER (HANTAAN VIRUS) AS A MEMBER OF THE BUNYAVIRIDAE , 1982, The Lancet.

[10]  M. Gallimore,et al.  Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma. , 1982, Thrombosis research.

[11]  D. Gajdusek,et al.  ÆTIOLOGICAL RELATION BETWEEN KOREAN HÆMORRHAGIC FEVER WITH RENAL SYNDROME IN PEOPLE'S REPUBLIC OF CHINA , 1980, The Lancet.

[12]  M. Brummer‐Korvenkontio,et al.  ÆTIOLOGICAL RELATION BETWEEN KOREAN HÆMORRHAGIC FEVER AND NEPHROPATHIA EPIDEMICA , 1979, The Lancet.

[13]  J. Mustard,et al.  Effect of viruses on platelet aggregation and platelet survival in rabbits. , 1978, Blood.

[14]  Y. Collan,et al.  Nephropathia epidemica: immunohistochemical study of pathogenesis. , 1978, Clinical nephrology.

[15]  K. Johnson,et al.  Isolation of the etiologic agent of Korean Hemorrhagic fever. , 1978, The Journal of infectious diseases.

[16]  J. Bach,et al.  Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol. , 1977, Journal of immunological methods.

[17]  M. Welch,et al.  Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. , 1976, Thrombosis research.

[18]  R. Winchester,et al.  Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. , 1970, Immunology.

[19]  E. Salzman MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE. , 1963, The Journal of laboratory and clinical medicine.

[20]  G. Born,et al.  Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.

[21]  S. E. Greisman Capillary observations in patients with hemorrhagic fever and other infectious illnesses. , 1957, The Journal of clinical investigation.

[22]  F. W. Furth Observations on the hemostatic defect in epidemic hemorrhagic fever. , 1954, The American journal of medicine.

[23]  R. B. Giles,et al.  The clinical course of epidemic hemorrhagic fever. , 1954, The American journal of medicine.

[24]  J. Smadel Epidemic hemorrhagic fever. , 1953, American journal of public health and the nation's health.

[25]  R. L. Hullinghorst,et al.  Pathology of epidemic hemorrhagic fever. , 1953, Annals of internal medicine.